Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW274150 in Rheumatoid Arthritis
NCT00379990Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of GW274150 in rheumatoid arthritis (RA), sponsored by GSK. Started Jan 2006; status: completed.
02
Drugs
GW274150
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00379990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379990.